Bioequivalence and Bioavailability Forum

❝ For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Dear Pharma_88,
It is essential to provide appropriate compensation to patients who participate in bioequivalence studies. The amount of compensation is typically subject to approval by the Ethics Committee, which assesses the proposed compensation to ensure that it is justified and ethical.